Specific deficiency of p56(lck) expression in T lymphocytes from type 1 diabetic patients

Journal of Immunology

Volumn 165, Issue 10, 2000, Pages 5874-5883

  Nervi, S ^a   Atlan Gepner, C ^a   Kahn Perles, B ^a   Lecine, P ^a   Vialettes, B ^a   Imbert, J ^a   Naquet, P ^a  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD69 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PROTEIN KINASE ZAP 70; PROTEIN P56; PROTEIN P59; PROTEIN P85; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; PHOSPHOTYROSINE; PROTEIN KINASE LCK;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; BIOSYNTHESIS; COHORT ANALYSIS; ENZYMOLOGY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INTERPHASE; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PHOSPHORYLATION; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; INTERPHASE; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MALE; MIDDLE AGED; PHOSPHORYLATION; PHOSPHOTYROSINE; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS;

EID: 0034668381     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.10.5874     Document Type: Article

References (65)

1. Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
2. Autoimmune diabetes: How many steps for one disease?
3. Genetic control of diabetes progression
4. Genetic control of autoimmune diabetes in the NOD mouse
5. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD
6. Defective T cell receptor/CD3 complex signaling in human type 1 diabetes
7. Constitutive impaired TCR/CD3-mediated activation of T cells in IDDM patients co-exist with normal co-stimulation pathways
8. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice
9. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function
10. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
11. Tumor necrosis factor-α and the progression of diabetes in non-obese diabetic mice
12. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-α and interleukin 1
13. Recombinant human tumor necrosis factor α suppresses autoimmune diabetes in nonobese diabetic mice
14. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus
15. T-cell anergy and altered T-cell receptor signaling: Effects on autoimmune disease
16. Transmembrane signalling through the T-cell-receptor-CD3 complex
17. T cell antigen receptor signal transduction: A tale of tails and cytoplasmic protein-tyrosine kinases
18. T cell clonal anergy
19. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells
20. Sequestration of p56(lck) by gp120, a model for TCR desensitization
21. Impaired plasma membrane targeting of Grb2-murine son of sevenless (mSOS) complex and differential activation of the Fyn-T cell receptor (TCR)-ζ-Cbl pathway mediate T cell hyporesponsiveness in autoimmune nonobese diabetic mice
22. Sequestration of CD4-associated Lck from the TCR complex may elicit T cell hyporesponsiveness in nonobese diabetic mice
23. Interleukin 2 and soluble interleukin 2-receptor secretion defect in vitro in newly diagnosed type I diabetic patients
24. T cell receptor-mediated signs and signals governing T cell development
25. Fidelity of T cell activation through multistep T cell receptor ζ phosphorylation
26. ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chain
27. p56(lck) interacts via its src homology 2 domain with the ZAP-70 kinase
28. Binding affinities of the SH2 domains of ZAP-70, p56(lck) and Shc to the ζ chain ITAMs of the T-cell receptor determined by surface plasmon resonance
29. Syk and ZAP-70 mediate recruitment of p56(lck)/CD4 to the activated T cell receptor/CD3/ζ complex
30. Localization of LAT in glycolipid-enriched microdomains is required for T cell activation
31. Interaction of the unique N-terminal region of tyrosine kinase p56(lck) with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs
32. Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains
33. Genetic evidence for the involvement of the Lck tyrosine kinase in signal transduction through the T cell antigen receptor
34. The role of p56(lck) and p59(fyn) tyrosine kinases and CD45 protein tyrosine phosphatase in T-cell development and clonal selection
35. The activation antigen CD69
36. Study of T-cell activation in type I diabetic patients and pre-type 1 diabetic subjects by cytometric analysis: Antigen expression defect in vitro
37. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation
38. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases
39. Structural requirements for enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56(lck)
40. Defective expression of p56(lck) in an infant with severe combined immunodeficiency
41. A single base mutation in the 5' splice site of intron 7 of the lck gene is responsible for the deletiori of exon 7 in lck mRNA of the JCaM1 cell line
42. Defective activation of p21(ras) in peripheral blood mononuclear cells from patients with insulin dependent diabetes mellitus
43. Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21(ras) activation
44. Engagement of CD4 and CD8 expressed on immature thymocytes induces activation of intracellular tyrosine phosphorylation pathways
45. Profound block in thymocyte development in mice lacking p56(lck)
46. Genetic evidence of a role for Lck in T-cell receptor function independent or downstream of ZAP-70/Syk protein tyrosine kinases
47. The Lck SH3 domain is required for activation of the mitogen-activated protein kinase pathway but not the initiation of T-cell antigen receptor signaling
48. T lymphocyte costimulation mediated by reorganization of membrane microdomains
49. Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains
50. Fatty acid compositions of serum lipids, erythrocytes, and platelets in insulin-dependent diabetic women
51. Selective expression of alternative (lck) mRNAs in human malignant cell lines
52. Structure of the two promoters of the human lck gene: Differential accumulation of two classes of lck transcripts in T cells
53. Alternative splicing in the human lck gene leads to the deletion of exon 1' and results in a new type II lck transcript
54. + ion links the cytoplasmic tail of CD4 and the N-terminal region of Lck
55. Genetic analysis of type 1 diabetes using whole genome approaches
56. Divergent changes in the sensitivity of maturing T cells to structurally related ligands underlies formation of a useful T cell repertoire
57. Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy
58. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
59. Decreased expression of signal-transducing CD3 ζ chains in T cells from the joints and peripheral blood of rheumatoid arthritis patients
60. p56(lck) activity and expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus
61. Restoration of expression of signal-transduction molecules in lymphocytes from patients with metastatic renal cell cancer after combination immunotherapy
62. Th1 and Th2 deviation of myelin-autoreactive T cells by altered peptide ligands is associated with reciprocal regulation of Lck, Fyn, and ZAP-70
63. Requirement for p56(lck) tyrosine kinase activation in Th subset differentiation
64. Different TH2-TH1 balance in Vβ8 and Vβ6 subsets of splenocytes in NOD females in the early phase of diabetogenesis
65. Absence of significant Th2 response in diabetes-prone non-obese diabetic (NOD) mice